Trial Details

COMPLETED
Basic Information
Clinical ID c4096
Identifier NCT01059344
Trial Title Efficacy and Safety of Asacol™ 4.8 g/Day (800 mg Tablets) for the Treatment of Active Ulcerative Colitis
Trial URL Visit Original Page
Study Information
Study Results

YES
Conditions Ulcerative Colitis
Interventions DRUG: Mesalamin
Participant Information
Sponsor Tillotts Pharma AG
City Homyel
Country/Region Belarus
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase PHASE3
Time Information
Start Date 2009-11
Primary Completion Date 2011-07
Completion Date 2011-08